214 related articles for article (PubMed ID: 31292446)
21. Decreased abundance of trefoil factor 1 transcript in the majority of gastric carcinomas.
Beckler AD; Roche JK; Harper JC; Petroni G; Frierson HF; Moskaluk CA; El-Rifai W; Powell SM
Cancer; 2003 Nov; 98(10):2184-91. PubMed ID: 14601088
[TBL] [Abstract][Full Text] [Related]
22. Cofactor of BRCA1: a novel transcription factor regulator in upper gastrointestinal adenocarcinomas.
McChesney PA; Aiyar SE; Lee OJ; Zaika A; Moskaluk C; Li R; El-Rifai W
Cancer Res; 2006 Feb; 66(3):1346-53. PubMed ID: 16452188
[TBL] [Abstract][Full Text] [Related]
23. Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways.
Yio X; Diamond M; Zhang JY; Weinstein H; Wang LH; Werther L; Itzkowitz S
Gastroenterology; 2006 May; 130(6):1696-706. PubMed ID: 16697734
[TBL] [Abstract][Full Text] [Related]
24. Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis.
Yang J; Qian S; Cai X; Lu W; Hu C; Sun X; Yang Y; Yu Q; Gao SP; Cao P
Mol Cancer Ther; 2016 Jun; 15(6):1190-200. PubMed ID: 26929249
[TBL] [Abstract][Full Text] [Related]
25. IFNγ-dependent silencing of TFF1 during
Eletto D; Mentucci F; Vllahu M; Voli A; Petrella A; Boccellato F; Meyer TF; Porta A; Tosco A
Open Biol; 2022 Dec; 12(12):220278. PubMed ID: 36514982
[TBL] [Abstract][Full Text] [Related]
26. Cytokine signalling via gp130 in gastric cancer.
Howlett M; Menheniott TR; Judd LM; Giraud AS
Biochim Biophys Acta; 2009 Nov; 1793(11):1623-33. PubMed ID: 19665497
[TBL] [Abstract][Full Text] [Related]
27. TFF1 Promotes EMT-Like Changes through an Auto-Induction Mechanism.
Romano E; Vllahu M; Bizzarro V; Belvedere R; Esposito R; Petrella A; Tosco A
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29997345
[TBL] [Abstract][Full Text] [Related]
28. Relationship between trefoil factor 1 expression and gastric mucosa injuries and gastric cancer.
Ren JL; Luo JY; Lu YP; Wang L; Shi HX
World J Gastroenterol; 2005 May; 11(17):2674-7. PubMed ID: 15849833
[TBL] [Abstract][Full Text] [Related]
29. Gastric TFF1 Expression from Acute to Chronic
Esposito R; Morello S; Vllahu M; Eletto D; Porta A; Tosco A
Front Cell Infect Microbiol; 2017; 7():434. PubMed ID: 29085807
[TBL] [Abstract][Full Text] [Related]
30. Role of trefoil factor 1 in gastric cancer and relationship between trefoil factor 1 and gastrokine 1.
Mao W; Chen J; Peng TL; Yin XF; Chen LZ; Chen MH
Oncol Rep; 2012 Oct; 28(4):1257-62. PubMed ID: 22842654
[TBL] [Abstract][Full Text] [Related]
31. Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm.
Yamaguchi J; Yokoyama Y; Kokuryo T; Ebata T; Enomoto A; Nagino M
J Clin Invest; 2018 Aug; 128(8):3619-3629. PubMed ID: 29809170
[TBL] [Abstract][Full Text] [Related]
32. TFF1 inhibits proliferation and induces apoptosis of gastric cancer cells in vitro.
Ge Y; Zhang J; Cao J; Wu Q; Sun L; Guo L; Wang Z
Bosn J Basic Med Sci; 2012 May; 12(2):74-81. PubMed ID: 22642590
[TBL] [Abstract][Full Text] [Related]
33. Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
Busch M; Große-Kreul J; Wirtz JJ; Beier M; Stephan H; Royer-Pokora B; Metz K; Dünker N
Int J Cancer; 2017 Aug; 141(3):549-560. PubMed ID: 28481041
[TBL] [Abstract][Full Text] [Related]
34. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130.
Judd LM; Alderman BM; Howlett M; Shulkes A; Dow C; Moverley J; Grail D; Jenkins BJ; Ernst M; Giraud AS
Gastroenterology; 2004 Jan; 126(1):196-207. PubMed ID: 14699500
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of TFF1 (pS2) expression by TNF-alpha in gastric epithelial cells.
Koike T; Shimada T; Fujii Y; Chen G; Tabei K; Namatame T; Yamagata M; Tajima A; Yoneda M; Terano A; Hiraishi H
J Gastroenterol Hepatol; 2007 Jun; 22(6):936-42. PubMed ID: 17565651
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimäki A
Cancer Res; 2003 Jun; 63(12):3032-6. PubMed ID: 12810622
[TBL] [Abstract][Full Text] [Related]
37. miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner.
Shi Y; Huang X; Chen G; Wang Y; Liu Y; Xu W; Tang S; Guleng B; Liu J; Ren J
BMC Cancer; 2019 Jan; 19(1):14. PubMed ID: 30612555
[TBL] [Abstract][Full Text] [Related]
38. Novel long non-coding RNA GACAT3 promotes gastric cancer cell proliferation through the IL-6/STAT3 signaling pathway.
Shen W; Yuan Y; Zhao M; Li J; Xu J; Lou G; Zheng J; Bu S; Guo J; Xi Y
Tumour Biol; 2016 Nov; 37(11):14895-14902. PubMed ID: 27644247
[TBL] [Abstract][Full Text] [Related]
39. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.
Judd LM; Bredin K; Kalantzis A; Jenkins BJ; Ernst M; Giraud AS
Gastroenterology; 2006 Oct; 131(4):1073-85. PubMed ID: 17030178
[TBL] [Abstract][Full Text] [Related]
40. TFF1 activates p53 through down-regulation of miR-504 in gastric cancer.
Soutto M; Chen Z; Saleh MA; Katsha A; Zhu S; Zaika A; Belkhiri A; El-Rifai W
Oncotarget; 2014 Jul; 5(14):5663-73. PubMed ID: 25015107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
